Single antiplatelet therapy

DRUG2 trials

Sponsors

China National Center for Cardiovascular Diseases, Ewha Womans University Mokdong Hospital

Conditions

Antithrombotic TherapyAtrial Fibrillation (AF)Bioprosthetic Valve ThrombosisCoronary Artery DiseaseDrug-eluting StentTranscatheter Aortic Valve Replacement

Phase 4

Antithrombotic Strategy Based on Clinical Events and 4D-CT for Patients After TAVR

China National Center for Cardiovascular DiseasesAntithrombotic Therapy, Bioprosthetic Valve Thrombosis, Transcatheter Aortic Valve Replacement

Start: 2023-07-27End: 2025-12-31Target: 650Updated: 2023-10-23

OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation

Not yet recruitingNCT07496281

Ewha Womans University Mokdong HospitalAtrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent

Start: 2027-03-01End: 2035-03-01Target: 2Updated: 2026-03-27

Related Papers

Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trial

BMJ Open2023-11-011 citations